Wedbush maintained Biogen (NASDAQ:BIIB) $263 price targetBy legume / May 23, 2023 / Biogen, Wedbush Wedbush analyst Laura Chico reiterates Biogen (NASDAQ:BIIB) with a Neutral and maintains $263 price target.